Supported by 30 human clinical trials, Oligonol® is a patented, low-molecular-weight polyphenolic extract derived from lychee fruit (85%) and green tea (15%) with excellent absorption and multiple anti-aging benefits.* It addresses the three major causes of aging: poor blood circulation, cell oxidation, and inflammation.*
MicroActive Oligonol is a recently introduced, micronized form of Oligonol that has exhibited significant sustained release activity in dissolution studies and increased residence time and absorption in a human study.
The results of this research show that MicroActive Oligonol boasts 2.39 times greater bioavailability than regular Oligonol.
MA Oligonol is dairy-free and made in the USA.
• Support healthy postmeal blood glucose and lipid levels*
• Reduce visceral fat*
• Lessen skin wrinkles and brown spots*
• Help decrease fatigue and improve endurance*
MicroActive® Oligonol® is a new, micronized form of Oligonol® that has demonstrated significant sustained release activity in dissolution studies and increased residence time and absorption in a human study. The results of this research indicate MicroActive® Oligonol®:
• Has 2.39 times greater bioavailability than standard Oligonol®
• Enables reduction of cost due to lower dosing requirement
• Has a 12-hour sustained release
The dissolution profile shows a sustained release of Oligonol® from the MicroActive® formulation. By 12 hours, ~95% of the dose was in solution in a micronized form, less than 10-micron particle size. With the control Oligonol® powder, nearly 95% of the dose was in solution by 4 hours.
A bioavailability clinical study showed that Oligonol® powder is absorbed rapidly and eliminated by ~8 hours postdose. The results of the study indicate that MicroActive® Oligonol® formulation extends the systemic exposure to higher levels of Oligonol®.
• 62% Oligonol®
• 50% polyphenols
• Oligonol® in a sustained-release matrix
• Brown powder
• Suitable for capsules and tablets